Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Oct 1;102(7):1352–1359. doi: 10.1172/JCI3795

A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor.

I Beau 1, P Touraine 1, G Meduri 1, A Gougeon 1, A Desroches 1, C Matuchansky 1, E Milgrom 1, F Kuttenn 1, M Misrahi 1
PMCID: PMC508982  PMID: 9769327

Abstract

A single natural loss of function mutation of the follicle stimulating hormone receptor (FSHR) has been described to date. Present in the Finnish population it markedly impairs receptor function, blocking follicle development at the primary stage and presenting as primary amenorrhea with atrophic ovaries. When Western European women with this phenotype were examined for FSHR mutations the result was negative, suggesting that other etiologies corresponding to this clinical pattern are markedly more frequent. We now describe a novel phenotype related to mutations provoking a partial loss of function of the FSHR. A woman with secondary amenorrhea had very high plasma gonadotropin concentrations (especially FSH), contrasting with normal sized ovaries and antral follicles up to 5 mm at ultrasonography. Histological and immunohistochemical examination of the ovaries showed normal follicular development up to the small antral stage and a disruption at further stages. The patient was found to carry compound heterozygotic mutations of the FSHR gene: Ile160Thr and Arg573Cys substitutions located, respectively, in the extracellular domain and in the third intracellular loop of the receptor. The mutated receptors, when expressed in COS-7 cells, showed partial functional impairment, consistent with the clinical and histological observations: the first mutation impaired cell surface expression and the second altered signal transduction of the receptor. This observation suggests that a limited FSH effect is sufficient to promote follicular growth up to the small antral stage. Further development necessitates strong FSH stimulation. The contrast between very high FSH levels and normal sized ovaries with antral follicles may thus be characteristic of such patients.

Full Text

The Full Text of this article is available as a PDF (431.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramowicz M. J., Duprez L., Parma J., Vassart G., Heinrichs C. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest. 1997 Jun 15;99(12):3018–3024. doi: 10.1172/JCI119497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aittomäki K., Herva R., Stenman U. H., Juntunen K., Ylöstalo P., Hovatta O., de la Chapelle A. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab. 1996 Oct;81(10):3722–3726. doi: 10.1210/jcem.81.10.8855829. [DOI] [PubMed] [Google Scholar]
  3. Aittomäki K., Lucena J. L., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., Kaskikari R., Sankila E. M., Lehväslaiho H., Engel A. R. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995 Sep 22;82(6):959–968. doi: 10.1016/0092-8674(95)90275-9. [DOI] [PubMed] [Google Scholar]
  4. Beau I., Misrahi M., Gross B., Vannier B., Loosfelt H., Hai M. T., Pichon C., Milgrom E. Basolateral localization and transcytosis of gonadotropin and thyrotropin receptors expressed in Madin-Darby canine kidney cells. J Biol Chem. 1997 Feb 21;272(8):5241–5248. doi: 10.1074/jbc.272.8.5241. [DOI] [PubMed] [Google Scholar]
  5. Bergh C., Howles C. M., Borg K., Hamberger L., Josefsson B., Nilsson L., Wikland M. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod. 1997 Oct;12(10):2133–2139. doi: 10.1093/humrep/12.10.2133. [DOI] [PubMed] [Google Scholar]
  6. Bick D., Franco B., Sherins R. J., Heye B., Pike L., Crawford J., Maddalena A., Incerti B., Pragliola A., Meitinger T. Brief report: intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N Engl J Med. 1992 Jun 25;326(26):1752–1755. doi: 10.1056/NEJM199206253262606. [DOI] [PubMed] [Google Scholar]
  7. Conway G. S. Premature ovarian failure. Curr Opin Obstet Gynecol. 1997 Jun;9(3):202–206. [PubMed] [Google Scholar]
  8. Dupont E., Luu-The V., Labrie F., Pelletier G. Light microscopic immunocytochemical localization of 3 beta-hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4-isomerase in the gonads and adrenal glands of the guinea pig. Endocrinology. 1990 Jun;126(6):2906–2909. doi: 10.1210/endo-126-6-2906. [DOI] [PubMed] [Google Scholar]
  9. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996 Apr;17(2):121–155. doi: 10.1210/edrv-17-2-121. [DOI] [PubMed] [Google Scholar]
  10. Gromoll J., Pekel E., Nieschlag E. The structure and organization of the human follicle-stimulating hormone receptor (FSHR) gene. Genomics. 1996 Jul 15;35(2):308–311. doi: 10.1006/geno.1996.0361. [DOI] [PubMed] [Google Scholar]
  11. Gromoll J., Simoni M., Nieschlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab. 1996 Apr;81(4):1367–1370. doi: 10.1210/jcem.81.4.8636335. [DOI] [PubMed] [Google Scholar]
  12. Groome N. P., Illingworth P. J., O'Brien M., Pai R., Rodger F. E., Mather J. P., McNeilly A. S. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 1996 Apr;81(4):1401–1405. doi: 10.1210/jcem.81.4.8636341. [DOI] [PubMed] [Google Scholar]
  13. Hardelin J. P., Levilliers J., del Castillo I., Cohen-Salmon M., Legouis R., Blanchard S., Compain S., Bouloux P., Kirk J., Moraine C. X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8190–8194. doi: 10.1073/pnas.89.17.8190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hillier S. G. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod. 1994 Feb;9(2):188–191. doi: 10.1093/oxfordjournals.humrep.a138480. [DOI] [PubMed] [Google Scholar]
  15. Inkster S. E., Brodie A. M. Expression of aromatase cytochrome P-450 in premenopausal and postmenopausal human ovaries: an immunocytochemical study. J Clin Endocrinol Metab. 1991 Oct;73(4):717–726. doi: 10.1210/jcem-73-4-717. [DOI] [PubMed] [Google Scholar]
  16. Kanis J. A. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994 Nov;4(6):368–381. doi: 10.1007/BF01622200. [DOI] [PubMed] [Google Scholar]
  17. Kitawaki J., Yoshida N., Osawa Y. An enzyme-linked immunosorbent assay for quantitation of aromatase cytochrome P-450. Endocrinology. 1989 Mar;124(3):1417–1423. doi: 10.1210/endo-124-3-1417. [DOI] [PubMed] [Google Scholar]
  18. Kominami S., Shinzawa K., Takemori S. Immunochemical studies on cytochrome P-450 in adrenal microsomes. Biochim Biophys Acta. 1983 Jan 25;755(2):163–169. doi: 10.1016/0304-4165(83)90199-x. [DOI] [PubMed] [Google Scholar]
  19. Kremer H., Kraaij R., Toledo S. P., Post M., Fridman J. B., Hayashida C. Y., van Reen M., Milgrom E., Ropers H. H., Mariman E. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet. 1995 Feb;9(2):160–164. doi: 10.1038/ng0295-160. [DOI] [PubMed] [Google Scholar]
  20. Kumar T. R., Wang Y., Lu N., Matzuk M. M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet. 1997 Feb;15(2):201–204. doi: 10.1038/ng0297-201. [DOI] [PubMed] [Google Scholar]
  21. Latronico A. C., Anasti J., Arnhold I. J., Rapaport R., Mendonca B. B., Bloise W., Castro M., Tsigos C., Chrousos G. P. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med. 1996 Feb 22;334(8):507–512. doi: 10.1056/NEJM199602223340805. [DOI] [PubMed] [Google Scholar]
  22. Laue L. L., Wu S. M., Kudo M., Bourdony C. J., Cutler G. B., Jr, Hsueh A. J., Chan W. Y. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol. 1996 Aug;10(8):987–997. doi: 10.1210/mend.10.8.8843415. [DOI] [PubMed] [Google Scholar]
  23. Laue L., Wu S. M., Kudo M., Hsueh A. J., Cutler G. B., Jr, Griffin J. E., Wilson J. D., Brain C., Berry A. C., Grant D. B. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet. 1995 Aug;4(8):1429–1433. doi: 10.1093/hmg/4.8.1429. [DOI] [PubMed] [Google Scholar]
  24. Layman L. C., Cohen D. P., Jin M., Xie J., Li Z., Reindollar R. H., Bolbolan S., Bick D. P., Sherins R. R., Duck L. W. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet. 1998 Jan;18(1):14–15. doi: 10.1038/ng0198-14. [DOI] [PubMed] [Google Scholar]
  25. Le Bivic A., Sambuy Y., Patzak A., Patil N., Chao M., Rodriguez-Boulan E. An internal deletion in the cytoplasmic tail reverses the apical localization of human NGF receptor in transfected MDCK cells. J Cell Biol. 1991 Nov;115(3):607–618. doi: 10.1083/jcb.115.3.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Matthews C. H., Borgato S., Beck-Peccoz P., Adams M., Tone Y., Gambino G., Casagrande S., Tedeschini G., Benedetti A., Chatterjee V. K. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet. 1993 Sep;5(1):83–86. doi: 10.1038/ng0993-83. [DOI] [PubMed] [Google Scholar]
  27. McNatty K. P., Makris A., De Grazia C., Osathanondh R., Ryan K. J. Steroidogenesis by recombined follicular cells from the human ovary in vitro. J Clin Endocrinol Metab. 1980 Dec;51(6):1286–1292. doi: 10.1210/jcem-51-6-1286. [DOI] [PubMed] [Google Scholar]
  28. Meduri G., Charnaux N., Loosfelt H., Jolivet A., Spyratos F., Brailly S., Milgrom E. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res. 1997 Mar 1;57(5):857–864. [PubMed] [Google Scholar]
  29. Meduri G., Vu Hai M. T., Jolivet A., Takemori S., Kominami S., Driancourt M. A., Milgrom E. Comparison of cellular distribution of LH receptors and steroidogenic enzymes in the porcine ovary. J Endocrinol. 1996 Mar;148(3):435–446. doi: 10.1677/joe.0.1480435. [DOI] [PubMed] [Google Scholar]
  30. Mehta A. E., Matwijiw I., Lyons E. A., Faiman C. Noninvasive diagnosis of resistant ovary syndrome by ultrasonography. Fertil Steril. 1992 Jan;57(1):56–61. [PubMed] [Google Scholar]
  31. Menon V., Edwards R. L., Butt W. R., Bluck M., Lynch S. S. Review of 59 patients with hypergonadotrophic amenorrhoea. Br J Obstet Gynaecol. 1984 Jan;91(1):63–66. doi: 10.1111/j.1471-0528.1984.tb05280.x. [DOI] [PubMed] [Google Scholar]
  32. Misrahi M., Meduri G., Pissard S., Bouvattier C., Beau I., Loosfelt H., Jolivet A., Rappaport R., Milgrom E., Bougneres P. Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab. 1997 Jul;82(7):2159–2165. doi: 10.1210/jcem.82.7.4039. [DOI] [PubMed] [Google Scholar]
  33. Rozzell T. G., Wang H., Liu X., Segaloff D. L. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not of the lutropin/choriogonadotropin receptor. Mol Endocrinol. 1995 Dec;9(12):1727–1736. doi: 10.1210/mend.9.12.8614409. [DOI] [PubMed] [Google Scholar]
  34. Segaloff D. L., Ascoli M. The lutropin/choriogonadotropin receptor ... 4 years later. Endocr Rev. 1993 Jun;14(3):324–347. doi: 10.1210/edrv-14-3-324. [DOI] [PubMed] [Google Scholar]
  35. Shangold M. M., Turksoy R. N., Bashford R. A., Hammond C. B. Pregnancy following the "insensitive ovary syndrome". Fertil Steril. 1977 Nov;28(11):1179–1181. doi: 10.1016/s0015-0282(16)42914-6. [DOI] [PubMed] [Google Scholar]
  36. Simoni M., Gromoll J., Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev. 1997 Dec;18(6):739–773. doi: 10.1210/edrv.18.6.0320. [DOI] [PubMed] [Google Scholar]
  37. Starup J., Sele V., Henriksen B. Amenorrhoea associated with increased production of gonadotrophins and a morphologically normal ovarian follicular apparatus. Acta Endocrinol (Copenh) 1971 Feb;66(2):248–256. doi: 10.1530/acta.0.0660248. [DOI] [PubMed] [Google Scholar]
  38. Tamura T., Kitawaki J., Yamamoto T., Osawa Y., Kominami S., Takemori S., Okada H. Immunohistochemical localization of 17 alpha-hydroxylase/C17-20 lyase and aromatase cytochrome P-450 in the human ovary during the menstrual cycle. J Endocrinol. 1992 Dec;135(3):589–595. doi: 10.1677/joe.0.1350589. [DOI] [PubMed] [Google Scholar]
  39. Themmen A. P., Brunner H. G. Luteinizing hormone receptor mutations and sex differentiation. Eur J Endocrinol. 1996 May;134(5):533–540. doi: 10.1530/eje.0.1340533. [DOI] [PubMed] [Google Scholar]
  40. Toledo S. P., Brunner H. G., Kraaij R., Post M., Dahia P. L., Hayashida C. Y., Kremer H Themmen A. P. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab. 1996 Nov;81(11):3850–3854. doi: 10.1210/jcem.81.11.8923827. [DOI] [PubMed] [Google Scholar]
  41. Vannier B., Loosfelt H., Meduri G., Pichon C., Milgrom E. Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor. Biochemistry. 1996 Feb 6;35(5):1358–1366. doi: 10.1021/bi952290f. [DOI] [PubMed] [Google Scholar]
  42. de Roux N., Misrahi M., Brauner R., Houang M., Carel J. C., Granier M., Le Bouc Y., Ghinea N., Boumedienne A., Toublanc J. E. Four families with loss of function mutations of the thyrotropin receptor. J Clin Endocrinol Metab. 1996 Dec;81(12):4229–4235. doi: 10.1210/jcem.81.12.8954020. [DOI] [PubMed] [Google Scholar]
  43. de Roux N., Young J., Misrahi M., Genet R., Chanson P., Schaison G., Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med. 1997 Nov 27;337(22):1597–1602. doi: 10.1056/NEJM199711273372205. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES